About: Need for sustainable biobanking networks for COVID-19 and other diseases of epidemic potential

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Need for sustainable biobanking networks for COVID-19 and other diseases of epidemic potential Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : wasabi.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
has title	Need for sustainable biobanking networks for COVID-19 and other diseases of epidemic potential
Creator	Nkengasong, John Wilder-Smith, Annelies Peeling, Rosanna Boeras, Debrah Sall, Amadou
Source	Elsevier; Medline; PMC
abstract	Outbreaks of infectious diseases are occurring with increasing frequency and unpredictability. The rapid development and deployment of diagnostics that can accurately and quickly identify pathogens as part of epidemic preparedness is needed now for the COVID-19 pandemic. WHO has developed a global research and innovation forum to facilitate, accelerate, and deepen research collaboration among countries and funders. Great progress has been made in the past decade, but access to specimens remains a major barrier for the development and evaluation of needed quality diagnostics. We present a sustainable model for a global network of country-owned biobanks with standardised methods for collection, characterisation, and archiving of specimens and pathogens to facilitate and accelerate diagnostics development and evaluation for COVID-19 and other diseases of epidemic potential. The biobanking network should be run on the guiding principles of transparency, equitable access, ethics, and respect for national laws that support country ownership and sustainability. Adapting the Nagoya Protocol on Access to Genetic Resources and the Fair and Equitable Sharing of Benefits, sharing of specimens from national biobanks can be rewarded through mechanisms such as equitable access to diagnostics at negotiated prices. Such networks should be prepared for any pathogen of epidemic potential.
has issue date	2020-07-24(xsd:dateTime)
bibo:doi	10.1016/s1473-3099(20)30461-8
bibo:pmid	32717208
has license	no-cc
sha1sum (hex)	3e6dd5974ec10f97cafe8c887fa85f0b9dac9fb3
schema:url	https://doi.org/10.1016/s1473-3099%2820%2930461-8
resource representing a document's title	Need for sustainable biobanking networks for COVID-19 and other diseases of epidemic potential
has PubMed Central identifier	PMC7380944
has PubMed identifier	32717208
schema:publication	Lancet Infect Dis
resource representing a document's body	covid:3e6dd5974ec10f97cafe8c887fa85f0b9dac9fb3#body_text
is schema:about of	named entity 'equitable' named entity 'innovation' named entity 'PROGRESS' named entity 'A MAJOR' named entity 'ACCELERATE' named entity 'DEPLOYMENT' named entity 'COLLABORATION' named entity 'NEEDED' named entity 'prepared' named entity 'standardised' named entity 'guiding' named entity 'equitable' named entity 'COVID-19' named entity 'network' named entity 'accurately' named entity 'pathogens' named entity 'forum' named entity 'decade' named entity 'Benefits' named entity 'Access' named entity 'sustainable model' named entity 'equitable access' named entity 'equitable access' named entity 'sustainability' named entity 'Genetic Resources' named entity 'pathogen' named entity 'infectious diseases' named entity 'development' named entity 'COVID19' named entity 'informed consent' named entity 'epidemic' named entity 'epidemic' named entity 'point of care' named entity 'Convention on Biological Diversity' named entity 'coronavirus' named entity 'Council for International Organizations of Medical Sciences' named entity 'UNICEF' named entity 'Africa' named entity 'UNICEF' named entity 'quarantine' named entity 'biobanking' named entity 'COVID19' named entity 'ethics' named entity 'quality control' named entity 'COVID19' named entity 'biobanking' named entity 'prevention and control' named entity 'diagnostic tests' named entity 'postmarketing surveillance' named entity 'Good Clinical Practice' named entity 'Africa' named entity 'Africa' named entity 'Zika outbreak' named entity 'Africa' named entity 'ensure the quality' named entity 'virus' named entity 'Epidemics' named entity 'antibody' named entity 'China' named entity 'CDC' named entity 'biobanking' named entity 'endemic' named entity 'POC' named entity 'molecular assay' named entity 'CDC' named entity 'molecular testing' named entity 'Research and Development' named entity 'COVID19' named entity 'tuberculosis' named entity 'vaccines' named entity 'biobanking' named entity 'surveil' named entity 'endemic' named entity 'molecular assay' named entity 'Nagoya Protocol' named entity 'World Bank' named entity 'epidemic'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software